Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intrathecal 60mg Prilocaine, Hyperbaric 40mg 9-chloroprocaine and 10.5mg Bupivacaine Each With Added Sufentanil (2µg) for Elective Ambulatory Umbilical and Unilateral Inguinal Herniorrhaphy

NCT02813382 is registered in ClinicalTrials.gov with AZ St.-Dimpna Geel as lead sponsor.

NCT NCT02813382
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02813382 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intrathecal 60mg Prilocaine, Hyperbaric 40mg 9-chloroprocaine and 10.5mg Bupivacaine Each With Added Sufentanil (2µg) for Elective Ambulatory Umbilical and Unilateral Inguinal Herniorrhaphy
Lead sponsor
AZ St.-Dimpna Geel
Phase
Observational
Overall status
Completed
Start date
August 31, 2015
Completion date
February 29, 2016
Enrollment
101 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

ambulatory surgical procedures, anesthesia, spinal, hernia, inguinal, hernia, umbilical